Multiple Epiphyseal Dysplasia – Talk Bio

Actionable Insights Powered by AI

Sanofi Invests €300M in Orano Med for Next-Generation Radioligand Therapies

6 months ago talkbio0Tagged 212Pb, AlphaMedix, Infrequent, Malignant Neoplasms, Multiple Epiphyseal Dysplasia, radioligand therapies, sanofi, targeted alpha, targeted alpha therapies

Sanofi, Orano Med, Radioligand Therapies, Rare Cancers, AlphaMedix, Lead-212 (212Pb), Targeted Alpha Therapies

Sanofi Enters Radiopharmaceutical Market with $110 Million Licensing Agreement

7 months ago talkbio0Tagged AlphaMedix, Multiple Epiphyseal Dysplasia, Neoplasms, Neurosecretory Systems, RadioMedix, Radiopharmaceuticals, sanofi

Sanofi, Radiopharmaceuticals, Licensing Deal, RadioMedix, Orano Med, AlphaMedix, Neuroendocrine Tumors